This is rooted in the observation that NAFLD is emerging from multiple parallel hits and involves inflammation, lipotoxicity, insulin resistance, and gut leakiness and dysbiosis [106,107,108,109,110]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.